2016 Volume 56 Issue 11 Pages 137-143
Insufficient anticoagulant therapy has become a focus of attention because its clinical improvement is definitely required for current venous thromboembolism (VTE) treatment in Japan. Direct oral anticoagulants (DOACs) have been approved for VTE treatment since 2014 and highly expected to provide better outcomes. Endovascular therapy for deep vein thrombosis (DVT) are also performed in several hospitals in Japan and seemed to be effective in severe cases. These novel treatment options should be employed for appropriate cases based on patients’ background, such as risk for bleeding complications, and its cost efficiency.
